English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessMarketsBiocon well-positioned to leverage opportunities from US drug patent expiries: CEO Siddharth Mittal

    Biocon well-positioned to leverage opportunities from US drug patent expiries: CEO Siddharth Mittal

    Biosimilars have led the growth in the April-June 2023 period and will continue to do so. The company also hopes to capitalise on its already strong presence in the US market, and stay ahead of the competition in the Indian market.

    Vaibhavi Ranjan
    August 18, 2023 / 15:20 IST
    Biocon CEO Siddharth Mittal
    • PRO Panorama

      Moneycontrol Pro Panorama | Gold or Bitcoin: Which has a more compelling story?

      Oct 10, 2025 / 03:07 PM IST

      In Moneycontrol Pro Panorama October 10 edition: Why World Bank wants South Asia to cut tariffs, market move a breakout, breakdown...

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts